Sebastian

Father and husband | Gastrointestinal Oncologist and Clinical Researcher at @ucchristus | @uvalpochile, @FacMedicinaUC & @mskcc alumni | Tweets are mine

[Anita Turk @anita_turk]

📢 Join myself, @SebasMondaca and @drholowatyj at #ASCO25 for a deep dive into the evolving landscape of #CRC care.
🔬 Biomarker-driven tx in mCRC
🧬 Neoadjuvant strategies in localized disease
📈 The rise of early-onset CRC
#crcsm #EOCRC #ASCO25

[Juan Briones Carvajal @juanbri13073297]

Una nueva oncóloga para Chile y la V Región.
Sin duda de lo mejor que a pasado por nuestra residencia de Oncología Médica UC. Brillante.

[José Peña @PenaDuranJose]

Instantáneas de hoy en el cierre del diplomado de oncología básica @FacMedicinaUC. Muy buena energía, gente motivada, ideas para el futuro. Gracias a quienes confiaron para aprender con nosotros, y por supuesto al equipo docente / administrativo! Si quiere hacerlo el 2025, DM

[Jash Datta, MD @DrJashDatta]

@DerekAOReilly @EileenMOReilly @CpcrMsk Beyond her obvious massive clinical + scientific contributions to the field, it is her kindness and empathy that makes her an exemplary ambassador for our profession! #pancsm

[Sebastian @SebasMondaca]

Very grateful for the opportunity to participate in this wonderful conference organized by Dr. Bob Li, @AsiaSocietyNY and @MSKCancerCenter. Collaboration trough bold initiatives like this one is the way to move forward. #cure4cancer

[Sociedad Chilena de Oncología Médica - SCOM @SChOncologia]

El Dr. Felipe Quezada, se refiere al cáncer colorrectal oligometastásico, en la Sesión Manejo de enfermedad oligometastásica, en las #JornadasSCOM2022.

#SCOM #Cáncer #Oncología #OncologíaMédica #CáncerColorrectal #Oligometástasis

[Benjamin Walbaum, MD @benjiwal]

Tremendous effort and work by my friend and colleague @SebasMondaca in this collaborative work between @FacMedicinaUC and @MSKCancerCenter lead by @GABOUALFA

[Ghassan Abou-Alfa @GABOUALFA]

Welcome back to @MSKCancerCenter and #NewYorkCity @SebasMondaca . @YJanjigianMD @GABOUALFA and all other dear colleagues were delighted to see you!

[Ghassan Abou-Alfa @GABOUALFA]

Congratulations on superb continued work @ucatolica @SebasMondaca Juan Carlos Roa Santiago Sepulveda to better understand #gallbladdercancer. @MSKCancerCenter @MSK_DeptOfMed @GABOUALFA and team, honored and delighted to continue this global collaboration with #Chile

[José Peña @PenaDuranJose]

Ya gente!!! Ayúdenme con la difusión de este tremendo diplomado que empezaremos en dos semanitas...
Hay un gran equipo docente y mucha dedicación detrás no se lo pierda!
Nota: si no es médico/a y lo encuentra muy caro me escribe DM

[Sebastian @SebasMondaca]

@YJanjigianMD @sloan_kettering Nothing like having such a great mentor and friend for dinner @YJanjigianMD.

[Sebastian @SebasMondaca]

@benjiwal @pashtoonkasi @manjuggm @TumorBoardTues @MPishvaian @DocCatenacci @VanMorrisMD @aparna1024 @DrKelseyKlute @marklewismd @GlopesMd @ShaalanBeg @EileenMOReilly @ASCO_pubs @ASCO @Benjohnson1112 @benweinbergmd @mtmdphd @mdmanishshah @BenWestphalen @BrandonMeyersMD @profevasegelov @Aiims1742 Only in the context of a clinical trial. Liquid biopsy is not ready for the prime time in this regard.

[Ghassan Abou-Alfa @GABOUALFA]

Busy week for hepatobiliary cancers: Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study https://t.co/a1cZEsRtA1

[Yelena Y. Janjigian MD @YJanjigianMD]

Excited for Feb 5 all star ⭐️ ⭐️⭐️⭐️⭐️⭐️ @sloan_kettering @nyulangone line up. Please register and participate in the expert discussion. @OncLiveSOSS @OncLive @GABOUALFA @ILSONDavid @MadameSurgeon @EileenMOReilly @CpcrMsk
free registration & food https://t.co/jLvpwM52Lj

[Eileen M O’Reilly @EileenMOReilly]

Terrific to see olaparib FDA approved today for gBRCA related pancreas cancer as maintenance therapy. Adds an option for subset of people @CpcrMsk @NEJM @TaliaGolan and many others including AZ, Merck!

[Sociedad Chilena de Oncología Médica - SCOM @SChOncologia]

Consideramos graves las acusaciones del ministro #Mañalich. Es de suma importancia recalcar que somos una sociedad científica y no lucramos con nuestros pacientes.

#SCOM #Oncología #SociedadChilenaDeOncologíaMédica

[Sociedad Chilena de Oncología Médica - SCOM @SChOncologia]

Carta al Director, publicada hoy en #LUN, elaborada por la Directiva de la Sociedad Chilena de #Oncología Médica (SCOM), a raíz de las declaraciones del ministro Mañalich ante la Comisión de Hacienda del Senado, el 25 de noviembre.

[Sebastian @SebasMondaca]

Great experience to participate in this project under the guidance of @GABOUALFA and Dr. Bob Li. We need more treatment alternatives in Gallbladder Cancer.

[Ghassan Abou-Alfa @GABOUALFA]

The new and rapidly evolving era of ERBB@ targeting for Gallbladder Cancer! Well done @SebasMondaca Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine https://t.co/w5iJ5DIOvP

[Ghassan Abou-Alfa @GABOUALFA]

The new and rapidly evolving era of ERBB@ targeting for Gallbladder Cancer! Well done @SebasMondaca Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine https://t.co/w5iJ5DIOvP